Drug Patents owned by Aprecia Pharms

1. Drug name - SPRITAM

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9339489 APRECIA PHARMS Rapid disperse dosage form containing levetiracetam Mar, 2034

(11 years from now)

US9669009 APRECIA PHARMS Rapid disperse dosage form containing levetiracetam Mar, 2034

(11 years from now)

US11160786 APRECIA PHARMS Rapid disperse dosage form Mar, 2034

(11 years from now)

Drugs and Companies using LEVETIRACETAM ingredient

Treatment: Method of administering levetiracetam; Method of administering levetiracetam under fasted conditions; method of administering levetiracetam; method of administering levetiracetam under fed conditions

Dosage: TABLET, FOR SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
1GM TABLET, FOR SUSPENSION;ORAL Prescription
250MG TABLET, FOR SUSPENSION;ORAL Prescription
500MG TABLET, FOR SUSPENSION;ORAL Prescription
750MG TABLET, FOR SUSPENSION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.